Literature DB >> 12105218

STAT3 activation by type I interferons is dependent on specific tyrosines located in the cytoplasmic domain of interferon receptor chain 2c. Activation of multiple STATS proceeds through the redundant usage of two tyrosine residues.

Sharlene Velichko1, T Charis Wagner, James Turkson, Richard Jove, Ed Croze.   

Abstract

Human type I interferons (IFNs) play an important role in the regulation of antiviral defense mechanisms, immunomodulatory activities, and growth control. Recent efforts have demonstrated the importance of IFNs in the activation of signal transducers and activators of transcription (STATs). The role of STAT1 and STAT2 in IFN-dependent JAK-STAT signaling is well established; however, the role of STAT3 and its activation by IFNs remains unclear. Understanding the IFN-dependent regulation of STAT3 is of increasing interest because recent studies have demonstrated that STAT3 may play a role in cancer. Studies have revealed that STAT3 is constitutively active in a number of cancer cell lines and that overexpression of an active form of STAT3 transforms normal fibroblasts. Therefore, STAT3 exhibits properties indicative of known oncogenes. In this report, we define the role of the type I IFN receptor in STAT3 activation and identify for the first time tyrosine residues present in the cytoplasmic domain of IFNAR2c that are critical for STAT3 activation. The regulation of STAT3 activation by IFNs was measured in a human lung fibrosarcoma cell line lacking IFNAR2c but stably expressing various IFNAR2c tyrosine mutants. We show here that in addition to IFN-dependent tyrosine phosphorylation of STAT3, activation using a STAT3-dependent electrophoretic mobility shift assay and a STAT3-specific reporter can also be demonstrated. Furthermore, we demonstrate that type I IFN-dependent activation of STAT3 proceeds through a novel mechanism that is dependent on two tyrosines, Tyr(337) and Tyr(512), present in IFNAR2c and contained within a conserved six-amino acid residue motif, GxGYxM. Surprisingly, both tyrosines were previously shown to be required for type I IFN-dependent STAT1 and STAT2 activation. Our results reveal that type I IFNs activate multiple STATs via the overlapping usage of two tyrosine residues located in the cytoplasmic domain of IFNAR2c.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12105218     DOI: 10.1074/jbc.M204578200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Regulation of epidermal growth factor receptor in human colon cancer cell lines by interferon alpha.

Authors:  J-L Yang; X-J Qu; P J Russell; D Goldstein
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

2.  A point mutation, E95D, in the mumps virus V protein disengages STAT3 targeting from STAT1 targeting.

Authors:  Mamta Puri; Ken Lemon; W Paul Duprex; Bertus K Rima; Curt M Horvath
Journal:  J Virol       Date:  2009-04-22       Impact factor: 5.103

3.  STAT3 ubiquitylation and degradation by mumps virus suppress cytokine and oncogene signaling.

Authors:  Christina M Ulane; Jason J Rodriguez; Jean-Patrick Parisien; Curt M Horvath
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

4.  STAT protein interference and suppression of cytokine signal transduction by measles virus V protein.

Authors:  Heidi Palosaari; Jean-Patrick Parisien; Jason J Rodriguez; Christina M Ulane; Curt M Horvath
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

Review 5.  JAK/STAT: Why choose a classical or an alternative pathway when you can have both?

Authors:  Léna Puigdevall; Camille Michiels; Clara Stewardson; Laure Dumoutier
Journal:  J Cell Mol Med       Date:  2022-03-03       Impact factor: 5.310

6.  Increased interferon alpha receptor 2 mRNA levels is associated with renal cell carcinoma metastasis.

Authors:  Takao Kamai; Yoshiaki Yanai; Kyoko Arai; Hideyuki Abe; Tomonori Yamanishi; Masashi Kurimoto; Ken-Ichiro Yoshida
Journal:  BMC Cancer       Date:  2007-08-15       Impact factor: 4.430

Review 7.  Viral manipulation of STAT3: Evade, exploit, and injure.

Authors:  Armando Andres Roca Suarez; Nicolaas Van Renne; Thomas F Baumert; Joachim Lupberger
Journal:  PLoS Pathog       Date:  2018-03-15       Impact factor: 7.464

Review 8.  A STAT3 of Addiction: Adipose Tissue, Adipocytokine Signalling and STAT3 as Mediators of Metabolic Remodelling in the Tumour Microenvironment.

Authors:  Rose Kadye; Mihlali Stoffels; Sidne Fanucci; Siso Mbanxa; Earl Prinsloo
Journal:  Cells       Date:  2020-04-22       Impact factor: 6.600

Review 9.  The Role of Type I Interferons in the Pathogenesis and Treatment of COVID-19.

Authors:  Gideon Schreiber
Journal:  Front Immunol       Date:  2020-09-30       Impact factor: 7.561

Review 10.  Germline STAT3 gain-of-function mutations in primary immunodeficiency: Impact on the cellular and clinical phenotype.

Authors:  Laura Faletti; Stephan Ehl; Maximilian Heeg
Journal:  Biomed J       Date:  2021-03-20       Impact factor: 4.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.